Jeff T. Huber

Jeff Huber is Co-Founder and General Partner of Triatomic Capital, a venture capital firm helping great entrepreneurs build ‘century-defining’ businesses & technologies (2022-present).

Jeff was the Founding CEO and Vice Chairman of GRAIL (2016-2021). GRAIL’s mission is to detect cancer early, when it can be cured.

Prior to GRAIL, Jeff was a Senior Vice President at Google. Over 13 years at Google, Jeff co-founded Google’s life sciences efforts in Google[x] (2013-2016), and led development and scaling for Google Maps (2011-2013), Google Apps (Gmail, Calendar, Docs, etc; 2005-2010), and Google Ads (2003-2011). As an executive at Google, Jeff oversaw 50x growth in revenues (from $1 billion to >$50 billion) and organization (1,000 to >50,000 employees), and managed a $5 billion P&L and large distributed teams (5,000+ direct-line employees). Earlier, Jeff was VP of architecture and systems development at eBay and SVP of engineering at Excite@Home.

Jeff was recognized as one of the ‘100 Most Intriguing Entrepreneurs’ (2017), and is an active early-stage investor/advisor in breakthrough life sciences and technology companies.

Jeff holds a bachelor’s degree in computer engineering from the University of Illinois, where he was Commencement Speaker (2016) and received a ‘Distinguished Alumni Award’ from the College of Electrical & Computer Engineering (2018) for ‘challenging the status quo through innovation’. He also holds a master’s degree in business from Harvard University, and was a Visiting Scholar in Stanford University’s Department of BioEngineering (2017-2020).

Jeff is a board member of Mammoth Biosciences, Manifold Bio, Electronic Arts (EA), Upstart (UPST), Openwater, Genalyte, Zapata Computing, and the Parker Institute for Cancer Immunotherapy (PICI), and is a former board member of GRAIL (2016-2021; acquired for $10.1B), Aldevron (2019-2021; acquired for $9.6B), Ancestry.com (2018-2020; acquired for $4.7B), Weta Digital (2020-2021; tech assets acquired for $1.625B), and Illumina (ILMN; 2014-2016).

Jeff is an advisory board member for Stanford’s Precision Health and Integrated Diagnostics Center (PHIND), for Duke University’s Research Translation & Commercialization (RTC) Council, and is chairman of the advisory board for the college of Computation, Data Science & Society (CDSS) at UC Berkeley, where he & his wife also sponsor the ‘Huber-Vossough Chancellor’s Chair’ in Computational Biomedicine.